Bayer · expansion
Bayer Plans $2.2 Billion Ohio Drug Manufacturing Campus
Bayer plans to invest $2.2 billion in a New Albany, Ohio pharmaceutical manufacturing campus, with its first production module expected to start operating in 2031.
Is Bayer's new Ohio plant already operational?
No. Bayer announced the investment on October 2, 2026; drug-substance manufacturing is expected to begin in 2031 and finished-drug manufacturing in 2034.
Orbitrum Investor Impact
Why does the Ohio investment matter for Bayer?
The project adds U.S. manufacturing capacity as the U.S. share of Bayer Pharmaceuticals' global revenue has risen to 35% from 20% in 2018, while management aims to double U.S. sales by the end of the decade.
Will the project immediately increase Bayer's revenue?
No. Production is not expected to start until 2031, so the near-term effect is a multi-year capital commitment rather than new manufacturing revenue from the site.
What are the next material milestones?
Bayer expects the drug-substance module to become operational in 2031 and a finished-drug manufacturing module to follow in 2034.
Sources
- Reuters — Bayer to invest $2.2 billion in new US pharma site
- Bayer — Bayer to invest 2.2 billion U.S. dollars in a new manufacturing site in the United States
Original signal: Reuters ↗
See more Orbitrum in Google
Add Orbitrum as a Preferred Source to make our research more likely to appear for you in Google Search.